1. Home
  2. ONMD vs PSTV Comparison

ONMD vs PSTV Comparison

Compare ONMD & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.24

Market Cap

71.4M

Sector

N/A

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$0.62

Market Cap

61.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
PSTV
Founded
2006
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.4M
61.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ONMD
PSTV
Price
$1.24
$0.62
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
2.6M
6.2M
Earning Date
11-14-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$494,000.00
$5,258,000.00
Revenue This Year
N/A
$28.21
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.16
52 Week High
$4.22
$2.31

Technical Indicators

Market Signals
Indicator
ONMD
PSTV
Relative Strength Index (RSI) 40.57 50.96
Support Level $1.46 $0.61
Resistance Level $2.30 $0.76
Average True Range (ATR) 0.24 0.05
MACD -0.01 0.01
Stochastic Oscillator 0.47 31.21

Price Performance

Historical Comparison
ONMD
PSTV

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: